Your browser doesn't support javascript.
loading
Declining antibody affinity over time after human vaccination with a Plasmodium falciparum merozoite vaccine candidate.
Persson, Kristina E M; Horton, Jessica L; Kurtovic, Liriye; McCarthy, James S; Anders, Robin F; Beeson, James G.
Affiliation
  • Persson KEM; Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Horton JL; Clinical Chemistry and Pharmacology, Laboratory Medicine, Region Skåne, Lund, Sweden.
  • Kurtovic L; Burnet Institute, Melbourne, Victoria, Australia.
  • McCarthy JS; Burnet Institute, Melbourne, Victoria, Australia.
  • Anders RF; QIMR-Berghofer Medical Research Institute, Queensland  Australia.
  • Beeson JG; Victorian Infectious Diseases Services, Doherty Institute, University of Melbourne, Australia.
J Infect Dis ; 2024 May 09.
Article in En | MEDLINE | ID: mdl-38723177
ABSTRACT
Maintaining high affinity antibodies after vaccination may be important for long-lasting immunity to malaria, but data on induction and kinetics of affinity is lacking. In a Phase 1 malaria vaccine trial, antibody affinity increased following a second vaccination but declined substantially over 12-months, suggesting poor maintenance of high affinity antibodies.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Infect Dis Year: 2024 Document type: Article Affiliation country: Suecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Infect Dis Year: 2024 Document type: Article Affiliation country: Suecia